MEKOPHAR Chemical Pharmaceutical Joint Stock Company
MEKOPHAR Chemical Pharmaceutical Joint Stock Company, commonly referred to as MEKOPHAR, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1977, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on generic medicines and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in Vietnam, MEKOPHAR is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of medications that cater to various therapeutic areas, setting it apart through rigorous quality control and adherence to international standards. Recognised for its market leadership, MEKOPHAR has achieved notable milestones, including certifications from global health authorities, which underscore its dedication to excellence in the pharmaceutical sector.
DitchCarbon Score
How does MEKOPHAR Chemical Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEKOPHAR Chemical Pharmaceutical Joint Stock Company's score of 10 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MEKOPHAR Chemical Pharmaceutical Joint Stock Company's reported carbon emissions
MEKOPHAR Chemical Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and reducing their carbon footprints. This trend often includes setting science-based targets and committing to various climate initiatives. However, without specific information from MEKOPHAR, it is unclear what their current strategies or commitments may be regarding carbon emissions and climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MEKOPHAR Chemical Pharmaceutical Joint Stock Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
